New Key Statistics Module, Z-Score and F-Score
BJSE:839729 Key Ratios
Market Cap ¥ M | 1,612.77 |
Enterprise Value ¥ M | 1,563.96 |
P/E(ttm) | 49.16 |
PE Ratio without NRI | 37.58 |
Forward PE Ratio | -- |
Price/Book | 2.54 |
Price/Sales | 5.80 |
Price/Free Cash Flow | 27.57 |
Price/Owner Earnings | 183.82 |
Payout Ratio % | 1.15 |
Revenue (TTM) ¥ M | 280.00 |
EPS (TTM) ¥ | 0.12 |
Beneish M-Score | -2.83 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 1.50 |
y-y EBITDA Growth Rate % | -64.20 |
EV-to-EBIT | 43.22 |
EV-to-EBITDA | 43.22 |
PEG | 25.05 |
Shares Outstanding M | 273.35 |
Net Margin (%) | 12.04 |
Operating Margin % | 14.26 |
Pre-tax Margin (%) | 13.27 |
Quick Ratio | 4.21 |
Current Ratio | 4.52 |
ROA % (ttm) | 4.21 |
ROE % (ttm) | 5.12 |
ROIC % (ttm) | 6.70 |
Dividend Yield % | 2.83 |
Altman Z-Score | 9.06 |
BJSE:839729 Number of Guru Trades
BJSE:839729 Volume of Guru Trades
Gurus Latest Trades with BJSE:839729
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
BJSE:839729 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Guangdong Winsun Bio Pharmaceutical Co Ltd Insider Transactions
No Available Data